Age-dependent cardiovascular, renal and endocrine responses to furosemide in conscious lambs

Clinical and Experimental Pharmacology and Physiology

Volumn 31, Issue 1-2, 2004, Pages 70-75

  Thomson, Julie J ^a   Smith, Francine G ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Arginine vasopressin; Diuretics; Furosemide; Neonate; Newborn; Perinatal; Renin

Indexed keywords

ARGIPRESSIN; FUROSEMIDE;

AGE; ANIMAL EXPERIMENT; ARTICLE; CARDIOVASCULAR RESPONSE; CONFIDENCE INTERVAL; CONSCIOUSNESS; CONTROLLED STUDY; DATA ANALYSIS; DOSE RESPONSE; DRUG EFFECT; DRUG MEGADOSE; ENDOCRINE FUNCTION; HORMONE RELEASE; INSTRUMENTATION; INTERMETHOD COMPARISON; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; LAMB; LOW DRUG DOSE; MEAN ARTERIAL PRESSURE; NONHUMAN; PLASMA RENIN ACTIVITY; URINE FLOW RATE; VENOUS PRESSURE;

AGING; ANIMALS; ARGININE VASOPRESSIN; BLOOD PROTEINS; DIURETICS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOCRINE SYSTEM; FUROSEMIDE; HEMATOCRIT; HEMODYNAMIC PROCESSES; INJECTIONS, INTRAVENOUS; KIDNEY; RENAL CIRCULATION; RENIN; SHEEP; URODYNAMICS;

EID: 1242269918     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2004.03952.x     Document Type: Article

References (36)

1. Seely JF, Dirks JH. Site of action of diuretic drugs. Kidney Int. 1977; 11: 1-8.
2. Wilcox CS, Mitch WE, Kelly RA et al. Response of the kidney to furosemide I. Effects of salt intake and renal compensation. J. Lab. Clin. Med. 1983; 102: 450-8.
3. Stokes W. A new effective diuretic: Lasix. BMJ 1964; 2: 910-14.
4. Seldin DW, Giebisch G. Diuretic Agents. Clinical Physiology and Pharmacology. Academic Press, San Diego. 1997.
5. Mirochnick MH, Miceli JJ, Kramer PA, Chapron DJ, Raye JR. Renal response to furosemide in very low birth weight infants during chronic administration. Dev. Pharmacol. Ther. 1990; 151: 1-7.
6. Aranda JV, Chemtob S, Laudignon N, Sasyniuk BI. Furosemide and vitamin E. Two problem drugs in neonatology. Pediatr. Clin. North Am. 1986; 33: 583-602.
7. Chemtob S, Kaplan BS, Sherbotie JR, Aranda JV. Pharmacology of diuretics in the newborn. Pediatr. Clin. North Am. 1989; 36: 1231-50.
8. Reiter PD, Makhlouf R, Stiles AD. Comparison of 6-hour infusion versus bolus furosemide in premature infants. Pharmacotherapy 1998; 18: 63-8.
9. Green TP, Thompson TR, Johnson DE, Lock JE. Furosemide promotes patent ductus arteriosus in premature infants with the respiratory-distress syndrome. N. Engl. J. Med. 1983; 308: 743-8.
10. Segar JL, Robillard JE, Johnson KJ, Bell EF, Chemtob S. Addition of metolazone to overcome tolerance to furosemide in infants with bronchopulmonary dysplasia. J. Pediatr. 1992; 120: 966-73.
11. de Wildt SN, Smith FG. Effects of the angiotensin converting enzyme (ACE) inhibitor, captopril, on the cardiovascular, endocrine and renal responses to furosemide in conscious lambs. Can. J. Physiol. Pharmacol. 1997; 75: 263-70.
12. Patel A, Smith FG. Dose-dependent cardiovascular, renal and endocrine effects of furosemide in conscious lambs. Can. J. Physiol. Pharmacol. 1997; 75: 1101-7.
13. Smith FG, Sener A, Hyland P. Chronic furosemide treatment alters renal responses to furosemide in conscious lambs. Pediatr. Nephrol. 2000; 14: 916-21.
14. Smith FG, Strack AM. Effects of renal denervation on cardiovascular response to furosemide in conscious lambs. Am. J. Physiol. 1995; 269: H149-52.
15. Smith FG, Abraham J. Renal and renin responses to furosemide in conscious lambs during postnatal maturation. Can. J. Physiol. Pharmacol. 1995; 73: 107-12.
16. Smith FG, Basati R, Sener A, Abu-Amarah I. Renin and heart rate responses to haemorrhage are age-dependent in conscious lambs. Exp. Physiol. 2000; 85: 287-93.
17. Brace RA. Blood volume in the fetus and methods for its measurement. In: Nathanielsz PW (ed.). Animal Models in Fetal Medicine IV. Perinatology Press, Ithaca. 1984; 19-36.
18. Haber E, Koerner T, Page LB, Kliman B, Purnode A. Application of a radioimmunoassay for angiotensin I to the physiological measurements of plasma renin activity in normal human subjects. J. Clin. Endocrinol. Metab. 1969; 29: 1349-55.
19. Skowsky WR, Rosenbloom A, Fisher DA. Radioimmunoassay measurement of arginine vasopressin in serum: Development and application. J. Clin. Endocrinol. Metab. 1974; 38: 278-87.
20. Mackay IG, Muir AL, Watson ML. Contribution of prostaglandins to the systemic and renal vascular response to frusemide in normal man. Br. J. Clin. Pharmacol. 1984; 17: 513-19.
21. MacDonald TM, Craig K, Watson ML. Frusemide, ACE inhibition, renal dopamine and prostaglandins: Acute interactions in normal man. Br. J. Clin. Pharmacol. 1989; 28: 683-94.
22. 1α: Relation to natriuresis, vasodilation, and renin release. Hypertension 1982; 4: 634-41.
23. Moore GK, Hook JB. Hemodynamic effects of furosemide in isolated perfused rat kidneys. Proc. Soc. Exp. Biol. Med. 1978; 158: 354-8.
24. Bailie MD, Barbour JA, Hook JB. Effects of indomethacin on furosemide-induced changes in renal blood flow. Proc. Soc. Exp. Biol. Med. 1975; 148: 1173-6.
25. Wiemer G, Fink E, Linz W, Hropot M, Scholkens BA, Wohlfart P. Furosemide enhances the release of endothelial kinins, nitric oxide and prostacyclin. J. Pharmacol. Exp. Ther. 1994; 271: 1611-15.
26. Smith FG, Chan S, de Wildt SN. Effects of renal denervation on cardiovascular and renal responses to ACE inhibition in conscious lambs. J. Appl. Physiol. 1997; 83: 414-19.
27. Velaphi SC, Roy T, Despain K, Rosenfeld CR. Differential responses to systemic and local angiotensin II infusions in conscious postnatal sheep. Pediatr. Res. 2002; 52: 333-41.
28. Siegel SR, Fisher DA. Ontogeny of the renin-angiotensin-aldosterone system in the fetal and newborn lamb. Pediatr. Res. 1980; 14: 99-102.
29. Siegel SR, Fisher DA. The renin-angiotensin-aldosterone system in the newborn lamb: Response to furosemide. Pediatr. Res. 1977; 11: 837-9.
30. de Lima J, Caillens J, Beaufils M, Ardaillou R. Effects of furosemide-induced plasma volume reduction on plasma antidiuretic hormone in normal and hypertensive subjects. Clin. Nephrol. 1981; 15: 246-51.
31. Kimura T, Minai K, Matsui K et al. Effect of various states of hydration and plasma ADH and renin in man. J. Clin. Endocrinol. Metab. 1976; 42: 79-87.
32. Olsson K, Fyhrquist F, Benlamlih S, Dahlborn K. Effects of captopril on arterial blood pressure, plasma renin activity and vasopressin concentration in sodium-repleted and sodium-deficient goats. Acta Physiol. Scand. 1984; 121: 73-80.
33. Schmitt S, Taylor K, Schmidt R, Van Orden D, Williamson HE. The role of volume depletion, antidiuretic hormone and angiotensin II in the furosemide-induced decrease in mesenteric conductance in the dog. J. Pharmacol. Exp. Ther. 1997; 219: 407-14.
34. Thrasher TN. Baroreceptor regulation of vasopressin and renin secretion: Low-pressure versus high-pressure receptors. Front. Neuroendocrinol. 1994; 15: 157-96.
35. Tsushima H, Mon M, Matsuda T. Microinjections of angiotensin II into the supraoptic and paraventricular nuclei produce potent antidiuresis by vasopressin release mediated through adrenergic and angiotensin receptors. Jpn. J. Pharmacol. 1994; 66: 241-6.
36. Bland RD, McMillan DD, Bressack MA. Decreased pulmonary transvascular fluid filtration in awake newborn lambs after intravenous furosemide. J. Clin. Invest. 1978; 62: 601-9.